Never miss another update

Subscribe Today!

iPharma Inhalation Labs Now Supporting GMP Drug/Device Release Testing for Pulmonary Clinical Phase 1 & 2 Studies

SAN FRANCISCO, CA / ACCESSWIRE / September 15, 2021 / iPharma Labs, Inc. (“iPharma”), a privately-held contract development research organization (CDRO) specializing in inhalation pharmaceutical development services, announced today the implementation of GMP services for release testing for inhalation clinical trials (phase 1 – 2). This achievement is important for the continued successful growth of… Read More »iPharma Inhalation Labs Now Supporting GMP Drug/Device Release Testing for Pulmonary Clinical Phase 1 & 2 Studies

The post iPharma Inhalation Labs Now Supporting GMP Drug/Device Release Testing for Pulmonary Clinical Phase 1 & 2 Studies appeared on Stocks News Feed.

Posted in

The Markets Today